We develop effective diagnostics technology aimed at fighting infectious diseases around the world
Lack of effective diagnostics is a leading cause of millions of lives lost to infectious diseases each year. Countless patients around the world also contract secondary infections from blood transfusion and other clinical contacts due to insufficient screening for the surging drug-resistant bacterial or viral pathogens. There is now an urgent need for portable, precise and globally affordable diagnostics solutions that would allow rapid response.
In spite of past innovations in technologies such as microfluidics to help with miniaturization, truly portable molecular diagnostics systems have largely eluded us due to lack of compact opto-electronic instrumentation.
We strive to solve this problem by introducing ultra low-light CMOS biosensors (e.g. Anitoa ULS24) that are highly sensitive and integrated, yet low cost to replace the bulky and expensive PMTs and CCDs in today's molecular testing instruments, to achieve portability.